CureDuchenne - Together we Can CureDuchenne
April 2013

Drisapersen Update Webinar with GSK on May 6

Drisapersen Webinar with GSK

You are invited to participate in a “Drisapersen Update” webinar with GSK on May 6 at 12 EST/9 a.m. PST. The purpose of the webinar is to update the Duchenne community about Phase II clinical trial results for GSK’s drisapersen drug for the treatment of Duchenne muscular dystrophy. GSK investigator John Kraus will present and answer submitted questions. CureDuchenne, in collaboration with MDA and PPMD, is pleased to co-sponsor this webinar.

If you have questions you would like to submit, please email us at with “Drisapersen Update” as the subject line. We will pass along all questions to GSK prior to the webinar. Please submit your questions no later than Thursday, May 2.

To register for the webinar, click here.